Topical Innovations is founded in 2016, and its Intellectual Property Platform consists of 2 patents relating to topical phenytoin for the treatment of chronic pain. These patents have been designed, based on insights in the development of topical analgesics gathered during more than a decade. From 2010 onwards a steady stream of papers have been published on the pain reducing effects and other benefits of topical analgesics.

The representatives of Topical Innovations have published several keystone publications in peer reviewed and PubMed indexed Journals. They designed a number of these publications together with Key Opinion Leaders in the field, in order to build a robust fundament for acceptance of this new technology. This strategy has led to a global visibility of the project in the world. For instance, we presented key aspects of our findings recently at meetings of the IASP and EFIC.